Mental Healthcare

Pediatric Antidepressant Prescription Rates Increased 66%

February 27, 2024 - A recent study published in Pediatrics, the journal of the American Academy of Pediatrics (AAP), revealed a significant increase in antidepressant prescriptions among adolescents, teens, and young adults between January 2016 and December 2022, indicating a decline in mental health following the COVID-19 pandemic. Researchers assessed data from the...

Read More


More Articles

GLP-1 Medication Use Is Linked with Lower Anxiety, Depression Rates

by Veronica Salib

On Tuesday, February 6, 2024, Epic Research published the results of a dual-team Cosmos study, highlighting that taking certain glucagon-like peptide-1 (GLP-1) receptor agonists may reduce the chances...

How the Medical Education System Contributes to Physician Burnout

by Veronica Salib

One could argue that the medical education system is the cornerstone of healthcare and patient care. Through the education and certification protocols, medical schools mold the providers that play a critical role in nearly every aspect of...

Understanding Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)

by Veronica Salib

Although most people think of selective serotonin reuptake inhibitors (SSRIs) when discussing antidepressants, serotonin and norepinephrine reuptake inhibitors (SNRIs) also play a critical role in managing major depressive disorder and...

Psilocybin-Assisted Group Therapy Manages MDD in Cancer Patients

by Veronica Salib

On December 18, 2023, researchers published a study in Cancer, a journal of the American Cancer Society, evaluating the safety, feasibility, and efficacy of psilocybin-assisted group therapy to manage...

Sage Therapeutics Announces Wholesale Cost of Zuranolone, $15,900

by Veronica Salib

On November 7, 2023, Sage Therapeutics, the manufacturer of ZURZUVAE (zuranolone), announced that the wholesale acquisition cost of the postpartum depression drug would be $15,900 for a 14-day...

Psychiatrists Prescribe or Recommend Ozempic, Other Weight Loss Drugs

by Veronica Salib

On November 3, 2023, the New York Times broke a story analyzing the role of Ozempic and other weight loss drugs in mental health or psychiatric care. Upon reaching out to 13 psychiatric departments at...

Pharmacy Workforce Conditions Drive 3-Day CVS, Walgreens Staff Walkout

by Veronica Salib

Through Wednesday, November 1, 2023, patients may have more difficulty obtaining prescriptions or getting vaccinated at their local pharmacy. According to a CNN report, CVS and Walgreens pharmacy...

Developing a Sustainable Pharmaceutical Workforce and Workplace

by Veronica Salib

In a press release by the American Pharmacists Association (APhA), released on September 27, 2023, the organization collaborated with the American Society of Health-System Pharmacists (ASHP) and the...

Managing Pediatric Behavioral Health with Pharmacological Treatments

by Veronica Salib

Pediatric mental and behavioral health is a large field of research that can be challenging to tackle. Although these conditions are already difficult to manage in adults, pediatric care requires even more consideration when approaching...

Understanding Pharmaceutical Drug Addiction: Types, Signs, Treatments

by Veronica Salib

Drug addiction and treatment have become an increasingly serious problem in the United States healthcare system. Substance use disorders are life-threatening mental illnesses that continue to take lives, alter families, and burden...

FDA Approves Zuranolone for Postpartum Depression

by Veronica Salib

Last week, the United States Food and Drug Administration approved the first oral treatment for postpartum depression (PPD). Zuranolone was approved on August 4, 2023, just days after a study in the...

Zuranolone Effectively and Safely Treats Postpartum Depression

by Veronica Salib

A study published in the American Journal of Psychiatry on July 26, 2023, proved that zuranolone could effectively and safely treat postpartum depression. The study supports the priority review granted...

Top 10 Myths About Medicinal and Recreational Cannabis

by Alivia Kaylor

Addressing the top 10 most common myths about medicinal and recreational cannabis is critical to promote informed decision-making, reduce stigma, and foster evidence-based discussions, leading to safer use and better public policies....

Top 3 Use Cases for Psychedelics, Understanding Ongoing Research

by Veronica Salib

Throughout the past decade, psychedelics have become a primary area of interest for ongoing clinical research. Scientists have hypothesized multiple clinical use cases for these medications despite primarily being scheduled or illicit...

Ketamine and ECT Equally Effective for Treatment-Resistant Depression

by Veronica Salib

An open-label, randomized, noninferiority trial published in the New England Journal of Medicine revealed that ketamine and electroconvulsive therapy (ECT) were equally effective at managing...

Oral Ketamine Treatment: An Alternative to Ketamine Infusions

by Veronica Salib

Data from the WHO estimates that 230 million people globally have depression. Although many traditional treatments exist for depression, roughly 33% of people do not respond to medications. As a result, researchers have searched for...

Less Than 55% of Pediatric Clinical Trial Results Are Published

by Veronica Salib

In a recent research letter published in JAMA Network Open, Chris A. Rees, MD, MPH, and his colleagues analyzed how pediatric clinical trial results are disseminated or made publicly available. Rees...

Long-Acting Injectable Antiretroviral Therapy Suppresses HIV

by Veronica Salib

An ongoing study supported by the NIH in San Francisco assessed the efficacy of long-acting antiretroviral therapy (LA-ART), administered via injection, for treating HIV. The study compared LA-ART to...

CDC Analyzes Sleep Medication Usage by Adults in the United States

by Veronica Salib

A recent National Center for Health Statistics (NCHS) analysis determined that 18.4% of adults in the United States took a sleep medication to fall or stay asleep in the past 30 days. The study...

Recent Articles